| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |